Send us Feedback

CVS Caremark Corporation (CVS)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

CVS » Topics » TABLE OF CONTENTS

This excerpt taken from the CVS 10-K filed Feb 27, 2009.

TABLE OF CONTENTS

 

Part I    Page
  Item 1:    Business    3
  Item 1A:    Risk Factors    18
  Item 1B:    Unresolved Staff Comments    22
  Item 2:    Properties    23
  Item 3:    Legal Proceedings    25
  Item 4:    Submission of Matters to a Vote of Security Holders    27
  Executive Officers of the Registrant    28
Part II   
  Item 5:    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities    30
  Item 6:    Selected Financial Data    31
  Item 7:    Management’s Discussion and Analysis of Financial Condition and Results of Operations    32
  Item 7A:    Quantitative and Qualitative Disclosures About Market Risk    32
  Item 8:    Financial Statements and Supplementary Data    32
  Item 9:    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure    32
  Item 9A:    Controls and Procedures    32
  Item 9B:    Other Information    33
Part III   
  Item 10:    Directors and Executive Officers of the Registrant    34
  Item 11:    Executive Compensation    34
  Item 12:    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters    34
  Item 13:    Certain Relationships and Related Transactions and Director Independence    34
  Item 14:    Principal Accountant Fees and Services    34
Part IV   
  Item 15:    Exhibits, Financial Statement Schedules    35
  Report of Independent Registered Public Accounting Firm    41
  Schedule II – Valuation and Qualifying Accounts    43
  Signatures    44

 

2

Table of Contents
This excerpt taken from the CVS 10-K filed Feb 27, 2008.

TABLE OF CONTENTS

 

Part I         Page

Item 1:

    Business    3

Item 1A:

    Risk Factors    19

Item 1B:

    Unresolved Staff Comments    22

Item 2:

    Properties    23

Item 3:

    Legal Proceedings    25

Item 4:

    Submission of Matters to a Vote of Security Holders    28

Executive Officers of the Registrant

   29

Part II

      

Item 5:

    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities    30

Item 6:

    Selected Financial Data    32

Item 7:

    Management’s Discussion and Analysis of Financial Condition and Results of Operations    32

Item 7A:

    Quantitative and Qualitative Disclosures About Market Risk    33

Item 8:

    Financial Statements and Supplementary Data    33

Item 9:

    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure    33

Item 9A:

    Controls and Procedures    34

Item 9B:

    Other Information    34

Part III

      

Item 10:

    Directors and Executive Officers of the Registrant    35

Item 11:

    Executive Compensation    35

Item 12:

    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters    35

Item 13:

    Certain Relationships and Related Transactions and Director Independence    35

Item 14:

    Principal Accountant Fees and Services    35

Part IV

      

Item 15:

    Exhibits, Financial Statement Schedules    36

Report of Independent Registered Public Accounting Firm

    42

Schedule II – Valuation and Qualifying Accounts

    44

Signatures

    45

 

2

Table of Contents
This excerpt taken from the CVS 10-K filed Mar 14, 2006.

TABLE OF CONTENTS

 

          Page

Part I

      

Item 1:

    Business    3

Item 1A:

    Risk Factors    6

Item 1B:

    Unresolved Staff Comments    7

Item 2:

    Properties    7

Item 3:

    Legal Proceedings    8

Item 4:

    Submission of Matters to a Vote of Security Holders    9

Executive Officers of the Registrant

   9

Part II

      

Item 5:

    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities    10

Item 6:

    Selected Financial Data    11

Item 7:

    Management’s Discussion and Analysis of Financial Condition and Results of Operations    11

Item 7A:

    Quantitative and Qualitative Disclosures About Market Risk    12

Item 8:

    Financial Statements and Supplementary Data    12

Item 9:

    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure    12

Item 9A:

    Controls and Procedures    12

Item 9B:

    Other Information    12

Part III

      

Item 10:

    Directors and Executive Officers of the Registrant    13

Item 11:

    Executive Compensation    13

Item 12:

    Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters    13

Item 13:

    Certain Relationships and Related Transactions    13

Item 14:

    Principal Accountant Fees and Services    13

Part IV

      

Item 15:

    Exhibits, Financial Statement Schedules    14

Report of Independent Registered Public Accounting Firm

    18

Schedule II – Valuation and Qualifying Accounts

    19

Signatures

    20

 

2

Table of Contents
This excerpt taken from the CVS 10-K filed Mar 16, 2005.

TABLE OF CONTENTS

 

          Page
Part I     

Item 1:

   

Business

    2

Item 2:

   

Properties

    5

Item 3:

   

Legal Proceedings

    6

Item 4:

   

Submission of Matters to a Vote of Security Holders

    7

Executive Officers of the Registrant

   7
Part II     

Item 5:

   

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

    8

Item 6:

   

Selected Financial Data

    9

Item 7:

   

Management’s Discussion and Analysis of Financial Condition and Results of Operation

    9

Item 7A:

   

Quantitative and Qualitative Disclosures About Market Risk

    10

Item 8:

   

Financial Statements and Supplementary Data

    10

Item 9:

   

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

    10

Item 9A:

   

Controls and Procedures

    10

Item 9B:

   

Other Information

    10
Part III     

Item 10:

   

Directors and Executive Officers of the Registrant

    11

Item 11:

   

Executive Compensation

    11

Item 12:

   

Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

    11

Item 13:

   

Certain Relationships and Related Transactions

    11

Item 14:

   

Principal Accountant Fees and Services

    11
Part IV     

Item 15:

   

Exhibits, Financial Statement Schedules

   12

Report of Independent Registered Public Accounting Firm

    16

Schedule II – Valuation and Qualifying Accounts

    17

Signatures

    18

 

1

Table of Contents

EXCERPTS ON THIS PAGE:

10-K
Feb 27, 2009
10-K
Feb 27, 2008
10-K
Mar 14, 2006
10-K
Mar 16, 2005

RELATED TOPICS for CVS:

"TABLE OF CONTENTS" elsewhere:

Amazon.com (AMZN)
Amgen (AMGN)
Gap (GPS)
Staples (SPLS)
Safeway (SWY)
Abbott Laboratories (ABT)
Costco Wholesale (COST)
Sprint Nextel (S)
Pfizer (PFE)
LOWES COMPANIES INC (LOW)
Home Depot (HD)
Bristol-Myers Squibb Company (BMY)
JOHNSON & JOHNSON (JNJ)
Macy's Inc. (M)
Sears Holdings (SHLD)
Best Buy (BBY)
Wal-Mart (WMT)
Aetna (AET)
Dell (DELL)
Target (TGT)
AmerisourceBergen Corporation (ABC)
AutoNation (AN)
BRAZILIAN DISTRIBUTION CO COMPANHIA BRASILEIRA DE DISTR CBD (CBD)
DELHAIZE GROUP (DEG)
Express Scripts (ESRX)
Marathon Oil (MRO)
Omnicare (OCR)
PETsMART (PETM)
Rite Aid (RAD)
SuperValu (SVU)
Teva Pharmaceutical Industries (TEVA)
Transcend Services (TRCR)
ULTRAPAR HOLDINGS INC (UGP)
Procter & Gamble Company (PG)
Goodyear Tire & Rubber Company (GT)
Medtronic (MDT)
UnitedHealth Group (UNH)
KOHLS CORPORATION (KSS)
Cardinal Health (CAH)
MedcoHealth Solutions (MHS)
Humana (HUM)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki